Regulatory role of nitric oxide on the cardiac Na,K-ATPase in hypertension

Physiological Research

Volumn 57, Issue SUPPL. 2, 2008, Pages

  Vlkovicova J ^a   Javorkova V ^a   Mezesova L ^a   Pechanova O ^a   Vrbjar, Norbert ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Heart; Hypertension; Nitric oxide; Sodium pump

Indexed keywords

EID: 45949107373     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. BERNÁTOVÁ I, PECHÁŇOVÁ O, BABÁL P, KYSELÁ S, ŠTVRTINA S, ANDRIANTSITOHAINA R: Wine polyphenols improve cardiovascular remodeling and vascular function in NO-deficient hypertension. Am J Physiol Heart Circ Physiol 282: H942-H948, 2002.
2. BERNÁTOVÁ I, PECHÁŇOVÁ O, ŠIMKO F: Captopril prevents NO-deficient hypertension and left ventricular hypertrophy without affecting nitric oxide synthase activity in rats. Physiol Res 45: 311-316, 1996.
3. BREDT DS, SNYDER SH: Isolation of nitric oxide synthethase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 87: 682-685, 1990.
4. CARDILLO C, KILCOYNE CM, CANNON III RO, PANZA JA: Interactions Between Nitric Oxide and Endothelin in the Regulation of Vascular Tone of Human Resistance Vessels In Vivo. Hypertension 35: 1237-1241, 2000.
5. CHEN S, YUAN C, CLOUGH D, HADDY FJ, PAMNANI MB: Role of digitalis-like substance in experimental insulin-dependent diabetes mellitus hypertension. J Cardiovasc Pharmacol 22(Suppl 2): S20-S21, 1993a.
6. CHEN S, YUAN C, CLOUGH D, SCHOOLEY J, HADDY FJ, PAMNANI MB: Role of digitalis-like substance in the hypertension of streptozotocin-induced diabetes in reduced renal mass rats. Am J Hypertens 6(5 Pt 1): 397-406, 1993b.
7. +-ATPase activity in the tail artery from L-NAME-treated rats. Life Sci 74: 613-627, 2003.
8. FIALOVÁ M, DLUGOŠOVÁ K, OKRUHLICOVÁ L, KRISTEK F, MANOACH M, TRIBULOVÁ N: Adaptation of the heart to hypertension is associated with maladaptive gap junction connexin-43 remodelling. Physiol Res 2007 Jan 2; [Epub ahead of print]
9. FRIEDMAN SM: Evidence for enhanced sodium transport in the tail artery of the spontaneously hypertensive rat. Hypertension 1: 572-582, 1979.
10. GEROVÁ M, KRISTEK F: Efficiency of NO Donors in Substituting Impaired Endogenous NO production: a functional and morphological study. Physiol Res 50:165-173, 2001.
11. +)-ATPase from normotensive and spontaneously hypertensive rats. Arch Int Pharmacodyn Ther 245: 139-144, 1980.
12. GUPTA S, MCARTHUR C, GRADY C, RUDERMAN NB: Stimulation of vascular Na,K-ATPase activity by nitric oxide: a cGMP-independent effect. Am J Physiol 266(5 Pt 2): H2146-H 2151, 1994.
13. +-ATPase activity by a protein kinase-C pathway in rabbit aorta. Am J Physiol 261:H38-H45, 1991.
14. GUZMAN NJ, FANG M-Z TANG S-S, INGELFINGER JR, GARG LG: Autocrine inhibition of Na+/K+-ATPase by nitric oxide in mouse proximal tubule epithelial cells. J Clin Invest 95: 2083-2088, 1995.
15. +-ATPase alpha-subunit gene expression in hypertension. Science 241: 221-223, 1988.
16. HUGHES AK, CLINE RC, KOHAN DE: Alterations in renal endothelin-1 production in the spontaneously hypertensive rat. Hypertension 20: 666-673, 1992.
17. JELICKS LA, GUPTA RK: Nuclear magnetic resonance measurement of intracellular sodium in the perfused normotensive and spontaneously hypertensive rat heart. Am J Hypertens 7: 429-435, 1994.
18. JONES AW: Ionic dysfunction and hypertension. In: Advances in Microcirculation. B ALTURA, E DAVIS, H HARDERS (eds), Karger, Basel, 1982, pp 134-159.
19. KAWAI N, YAMAMOTO T, YAMAMOTO H, MCCARRON RM, SPATZ M: Endothelin 1 stimulates Na+,K(+)-ATPase and Na(+)-K(+)-Cl- cotransport through ETA receptors and protein kinase C-dependent pathway in cerebral capillary endothelium. J Neurochem 65:1588-1596, 1995.
20. LEHOTSKÝ J, KAPLÁN P, RAČAY P, MATEJOVIČ OVÁ M, DRGOVÁ A, MÉZEŠOVÁ V: Membrane ion transport systems during oxidative stress in rodent brain: protective effect of stobadine and other antioxidants. Life Sci 65: 1951-1958, 1999.
21. LERMAN A, EDWARDS BS, HALLETT JW, HEUBLEIN DM, SANDBERG SM, BURNETT JC Jr: Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 325: 997-1001, 1991.
22. LIANG M, KNOX FG: Nitric oxide activates PKCα and inhibits Na+-K+-ATPase in opossum kidney cells. Am J Physiol 277: F859-F865, 1999.
23. LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ: Protein measurement with the folin phenol reagent. J Biol Chem 193: 265-275, 1951.
24. MALINSKI T, KAPTURCZAK M, DAYHARSH J, BOHR D: Nitric oxide synthase activity in genetic hypertension. Biochem Biophys Res Commun 194: 654-658, 1993.
25. MINAMI N, IMAI Y, HASHIMOTO J-I, ABE K: Contribution of vascular nitric oxide to basal blood pressure in conscious spontaneously hypertensive and normotensive Wistar Kyoto rats. Clin Sci 89: 177-182, 1995.
26. NAVA E, NOLL G, LUcombining double acute accent SCHER TF: Increased activity of constitutive nitric oxide synthase in cardiac endothelium in spontaneous hypertension. Circulation 91: 2310-2313, 1995.
27. OKRUHLICOVÁ L, TRIBULOVÁ N, BERNÁTOVÁ I, PECHÁNOVÁ O: Induction of angiogenesis in nitric oxide-deficient rat heart. Physiol Res 49: 71-76, 2000.
28. OKRUHLICOVÁ L, TRIBULOVÁ N, WEISMANN P, SOTNÍKOVÁ R: Ultrastructure and histochemistry of rat myocardial capillary endothelial cells in response to diabetes and hypertension. Cell Res 15: 532-538, 2005.
29. PECHÁŇOVÁ O, BERNÁTOVÁ I, BABÁL P, MARTINEZ MC, KYSELÁ S, ŠTVRTINA S, ANDRIANTSITOHAINA R: Red wine polyphenols prevent cardiovascular alterations in L-NAME-induced hypertension. J Hypertens 22:1551-1559, 2004.
30. PECHÁNOVÁ O, BERNÁTOVÁ I, PELOUCH V, SIMKO F: Protein remodelling of the heart in NO-deficient hypertension: the effect of captopril. J Mol Cell Cardiol 29: 3365-3374, 1997.
31. PECHÁŇOVÁ O, ŠIMKO F: The role of nitric oxide in the maintenance of vasoactive balance. Physiol Res 2007 Sep 5 [Epub ahead of print]
32. PRASANNA G, DIBAS A, HULET C, YORIO T: Inhibition of Na(+)/K(+)-atpase by endothelin-1 in human nonpigmented ciliary epithelial cells. J Pharmacol Exp Ther 296: 966-971, 2001.
33. RAUCHOVÁ H, VOKURKOVÁ M, DOBEŠOVÁ Z, KUNEŠ J, ZICHA J: Erythrocyte ion transport in rats subjected to acute and chronic hypobaric hypoxia. Physiol Res 55: 711-713, 2006.
34. RAVINGEROVÁ T, DŽURBA A, VRBJAR N, TRIBULOVÁ N, ZIEGELHÖFFER A, SLEZÁK J: Free oxygen radicals-induced impairment of hearth function: the role of Na,K-ATPase. Pharmacol (Life Sci Adv) 13: 133-140, 1994.
35. REDONDO J, PEIRO C, RODRIGUEZ-MANAS L, SALAICES M, MARIN J, SANCHEZ-FERRER CF: Endothelial Stimulation of Sodium Pump in Cultured Vascular Smooth Muscle. Hypertension 26: 177-185, 1995.
36. +-ATPase by oxyradical generating systems. Mol Cell Biochem 147: 139-144, 1995.
37. TRIBULOVÁ N, OKRUHLICOVÁ L, BERNÁTOVÁ I, PECHÁNOVÁ O: Chronic impairment of nitric oxide production results in histochemical and subcellular alterations of the rat heart. Physiol Res 49: 77-88, 2000.
38. VLKOVIČOVÁ J, JAVORKOVÁ V, PECHÁŇ OVÁ O, VRBJAR N: Gender difference in functional properties of Na,K-ATPase in the heart of spontaneously hypertensive rats. Life Sci. 76: 971-82, 2005.
39. VRBJAR N, BERNÁTOVÁ I, PECHÁŇOVÁ O: Changes of sodium and ATP affinities of the cardiac (Na,K)-ATPase during and after nitric oxide deficient hypertension. Mol Cell Biochem 202: 141-147, 1999a.
40. VRBJAR N, BERNÁTOVÁ I, PECHÁŇOVÁ O: Functional alterations of cardiac (Na,K)-ATPase in L-NAME induced hypertension. Gen Physiol Biophys 18 (Suppl. 1): 10-12, 1999b.
41. VRBJAR N, PECHÁŇOVÁ O: Sodium and ATP affinities of the cardiac (Na,K)-ATPase in relation to nitric oxide synthesis in spontaneously hypertensive rats. Life Sci 71: 1751-1761, 2002.
42. +)-ATPase. Gen Physiol Biophys 3:317-325, 1984.
43. XU KY, KUPPUSAMY SP, WANG JQ, LI H, CUI H, DAWSON TM, HUANG PL, BURNETT AL, KUPPUSAMY P, BECKER LC: Nitric oxide protects cardiac sarcolemmal membrane enzyme function and ion active transport against ischemia-induced inactivation. J Biol Chem 278: 41798-41803, 2003.
44. XU KY, ZWEIER JL, BECKER LC: Oxygen-free radicals directly attack the ATP binding site of the cardiac Na, K-ATPase. Ann NY Acad Sci 834: 680-683, 1997.
45. ZEIDEL ML, BRADY HR, KONE BC, GULLANS SR, BRENNER BM: Endothelin, a peptide inhibitor of Na(+)-K(+)-ATPase in intact renaltubular epithelial cells. Am J Physiol 257(6 Pt 1): C1101-C1107, 1989.
46. WIECZOREK I, HAYNES WG, WEBB DJ, LUDLAM CA, FOX KA: Raised plasma endothelin in unstable angina and non-Q wave myocardial infarction: relation to cardiovascular outcome. Br Heart J 72: 436-441, 1994.
47. ZICHA J, KUNEŠ J: Membrane defects and the development of hypertension. In: Development of the Hypertensive Phenotype: Basic and Clinical Studies. Handbook of Hypertension. R McCARTY, DA BIZARD, RL. CHEVALIER (eds), Elsevier Science, 1999, Vol. 19, pp 213-251.
48. ZHOU L, BURNETT AL, HUANG PL, BECKER LC, KUPPUSAMY P, KASS DA, KEVIN DONAHUE J, PROUD D, SHAM JS, DAWSON TM, XU KY: Lack of nitric oxide synthase depresses ion transporting enzyme function in cardiac muscle. Biochem Biophys Res Commun 294: 1030-1035, 2002.
49. ZHOU L, KUPPUSAMY SP, BECKER LC, LI H, DAWSON TM, BURNETT AL, XU KY: Irreversible injury of nitric oxide synthase associated with cardiac sarcolemma membrane following global ischemia. Circulation 102(Suppl. II): 756, 2000.
50. ZHOU L, ZHOU Q, XIONG XQ, LIU JX, HE W: Influence of daidzein on left ventricular remodeling in rats with hypertrophic myocardium induced by pressure overload. Zhongguo Zhong Yao Za Zhi 32:1449-1452, 2007.